51919-71-2 Usage
General Description
Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is a chemical compound with the molecular formula C9H9NO4S. It is characterized by a methyl ester functional group, a nitro group, and a methylsulfanyl group attached to a benzene ring. methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is commonly used in organic synthesis as a reagent for the preparation of various organic compounds. It is known for its mild, versatile, and reliable performance in a wide range of reactions. Methyl 4-(methylsulfanyl)-3-nitrobenzenecarboxylate is also considered a valuable building block for the production of pharmaceuticals, agrochemicals, and other fine chemicals due to its potential applications in medicinal chemistry and other research fields.
Check Digit Verification of cas no
The CAS Registry Mumber 51919-71-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,1 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 51919-71:
(7*5)+(6*1)+(5*9)+(4*1)+(3*9)+(2*7)+(1*1)=132
132 % 10 = 2
So 51919-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO4S/c1-14-9(11)6-3-4-8(15-2)7(5-6)10(12)13/h3-5H,1-2H3
51919-71-2Relevant articles and documents
COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
